Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-6.68	-3.82	-0.94	-9.02	-1.96	-27.97
Depreciation & Amortization	3.38	1.15	0.9	1.77	0.46	0.65
Other Amortization	1.56	1.11	0.12	0.13	0.15	0.12
Loss (Gain) From Sale of Assets	-	-	-	-	-0.18	-
Stock-Based Compensation	5.17	3.17	3.14	4.22	3.38	2.58
Other Operating Activities	3.73	0.07	0.07	0.06	-0.37	1.26
Change in Accounts Receivable	-8.66	-3.12	-1.56	3.62	-5.42	0.43
Change in Inventory	-5.58	-1.31	-0.35	-0.01	0.69	-0.86
Change in Accounts Payable	11.57	2.32	0.05	-0.01	-0.57	1.77
Change in Other Net Operating Assets	16.82	1.41	5.39	4.06	-0.91	-0.32
Operating Cash Flow	21.31	0.97	6.82	4.82	-4.72	-22.35
Operating Cash Flow Growth	904.72%	-85.78%	41.36%	-	-	-
Capital Expenditures	-0.3	-0.03	-	-0.04	-0.01	-0.05
Sale of Property, Plant & Equipment	-	-	-	-	0.7	-
Cash Acquisitions	-30	-30	-	-	-	-
Sale (Purchase) of Intangibles	-8.12	-9.99	-0.78	-2.75	-3.25	-
Investing Cash Flow	-38.42	-40.01	-0.78	-2.79	-2.56	-0.05
Long-Term Debt Issued	-	25.31	-	-	-	2.48
Long-Term Debt Repaid	-	-1.16	-1.16	-0.39	-0.15	-
Net Debt Issued (Repaid)	25.31	24.15	-1.16	-0.39	-0.15	2.48
Issuance of Common Stock	8.66	8.44	0.38	0.25	0.54	29.15
Repurchase of Common Stock	-	-	-0.18	-	-	-
Financing Cash Flow	33.97	32.59	-0.96	-0.13	0.39	31.63
Net Cash Flow	16.86	-6.45	5.08	1.9	-6.89	9.23
Free Cash Flow	21.01	0.94	6.82	4.78	-4.73	-22.4
Free Cash Flow Growth	897.34%	-86.16%	42.48%	-	-	-
Free Cash Flow Margin	29.89%	2.42%	21.54%	22.51%	-21.66%	-57425.64%
Free Cash Flow Per Share	0.79	0.04	0.27	0.19	-0.19	-1.07
Cash Interest Paid	2.54	0.67	0.84	0.73	0.82	0.8
Cash Income Tax Paid	0.02	0.08	0.25	-	-	-
Levered Free Cash Flow	-0.16	-18.78	5.6	5.36	-7.02	-13.11
Unlevered Free Cash Flow	1.34	-18.64	6.15	5.83	-6.52	-12.68
Change in Working Capital	14.16	-0.7	3.53	7.66	-6.21	1.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q